{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:24:42Z","timestamp":1762507482832,"version":"3.37.3"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013261","name":"Guangdong Provincial Key Laboratory","doi-asserted-by":"publisher","award":["2014B030301035"],"award-info":[{"award-number":["2014B030301035"]}],"id":[{"id":"10.13039\/100013261","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Southern China International Cooperation Base","award":["2015B050501003"],"award-info":[{"award-number":["2015B050501003"]}]},{"name":"Guangzhou Clinical Research and Translational Center","award":["201604020010"],"award-info":[{"award-number":["201604020010"]}]},{"name":"Guangdong Provincial Engineering Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.008","type":"journal-article","created":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T07:24:06Z","timestamp":1535873046000},"page":"3463-3472","source":"Crossref","is-referenced-by-count":5,"title":["Closure versus Medical Therapy for Patent Foramen Ovale in Patients with Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"27","author":[{"given":"Baoshan","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0001","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrcardio.2010.224","article-title":"Patent foramen ovale: anatomy, outcomes, and closure","volume":"8","author":"Calvert","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0003","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.110.961920","article-title":"Paradoxical embolism","volume":"122","author":"Maron","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0004","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0005","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0006","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0007","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0008","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0009","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.carrev.2013.08.010","article-title":"Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: comprehensive systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Hakeem","year":"2013","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0011","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the defense-pfo trial","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0012","first-page":"e1","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"Epidemiol Biostat Public Health"},{"year":"2008","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"Higgins","key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0013"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0014","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0015","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJMe1301680","article-title":"Still no closure on the question of PFO closure","volume":"368","author":"Mess\u00e9","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0016","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1056\/NEJMe1201173","article-title":"Patent foramen ovale closure\u2013closing the door except for trials","volume":"366","author":"Johnston","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0017","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M17-2679","article-title":"Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis","volume":"168","author":"Shah","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0018","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","article-title":"Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis","volume":"49","author":"Ntaios","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0019","article-title":"Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials","author":"Ahmad","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0020","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005736","article-title":"Network meta-analysis of patent foramen ovale management strategies in cryptogenic stroke","author":"Saber","year":"2018","journal-title":"NEUROLOGY"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0021","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","article-title":"Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism","volume":"5","author":"Agarwal","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0022","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.111.030494","article-title":"Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism","volume":"125","author":"Wahl","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0023","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ccd.22172","article-title":"New onset atrial fibrillation after patent foramen ovale closure","volume":"74","author":"Stephan Staubach","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0024","first-page":"91","article-title":"Patent foramen ovale and cryptogenic stroke in older patients","volume":"369","author":"Handke","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0025","first-page":"209","article-title":"Comparison of outcome after patent foramen ovale closure in older versus younger patients","volume":"7","author":"Luermans","year":"2011","journal-title":"Eurointervention J Europcr Collab Working Group Interv Cardiol Eur Soc Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0026","first-page":"1740","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both","volume":"11","author":"Mas","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.008_bib0027","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/01.STR.29.5.944","article-title":"Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke","volume":"29","author":"Steiner","year":"1998","journal-title":"Stroke"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718304506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718304506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T21:46:02Z","timestamp":1569188762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718304506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1052305718304506"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.08.008","relation":{},"ISSN":["1052-3057"],"issn-type":[{"type":"print","value":"1052-3057"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}